Efeitos da terapia multidisciplinar sobre os marcadores inflamatórios em mulheres obesas com e sem baixa estatura

• Autor(a) principal: Carnaúba, Renata Ferreira
• Data de Publicação: 2017
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da Universidade Federal de Alagoas (UFAL)
• Texto Completo: http://www.repositorio.ufal.br/handle/riufal/3565
• topic: Obesidade - Mulheres; Baixa estatura; Marcadores inflamatórios; Obesity; Stature; Inflammatory markers; CNPQ::CIENCIAS DA SAUDE::NUTRICAO

In Brazil, the last national population survey, observed that the prevalence of obesity was 20.3% among individuals over 18 years of age, when analyzed according to sex and schooling, it is observed that women with lower levels of schooling have a higher prevalence 25, 2%. Height in adults is a widely used nutritional marker, which reflects the interaction between genetic inheritance and environmental exposure throughout life, so for an assessment of the broad nutritional status it is also necessary to assess height. The prevalence of obesity-related comorbidities is more pronounced in populations with lower height, with an increase in blood pressure, LDL-cholesterol levels, atherosclerotic plaque numbers, prevalence of diabetes mellitus and reduction of HDL- Cholesterol in adults. Obesity is characterized by a low-grade chronic inflammatory picture, leading to inflammatory responses related to excess body fat resulting from increased local and systemic production of cytokines and adipokines, including C-reactive protein (CRP), tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), leptin and plasminogen activator inhibitor 1, and reduction of adiponectin and interleukin 10 (IL-10). These act as a trigger in the progression of atherosclerosis. Aiming to contribute to the discussion of the problem, this dissertation presents: a review chapter on obesity and the mechanisms of physiological adaptation due to malnutrition in the beginning of life; The second article refers to a non-random clinical trial with a three-month follow-up that compared the metabolic and inflammatory profile of obese women with short stature and without short stature submitted to interdisciplinary therapy for weight loss.